Aerosolized antibiotics have advantages, drawbacks for ICU pneumonia

11/12/2012 | Medscape (free registration)

Using aerosolized antibiotics with ventilator-associated pneumonia patients can help avoid systemic antimicrobial exposure, but there remain drawbacks. In this interview, Michael E. Klepser from Ferris State University College of Pharmacy, in Big Rapids, Mich., says there is a risk for bacteremia in patients. "There's also considerable variation in the ability of different nebulizers to deliver a drug to the patient. As a result, each nebulizer–antibiotic combination may need to be evaluated to determine the stability and delivery characteristics," Klepser said.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD